Delcath Systems, Inc.
DCTHDelcath Systems, Inc. in brief
Delcath Systems, Inc. is a listed company in the Medical Devices industry, based in Delaware, USA. Its market value was $500 M on 20 October 2026, which makes it the 12,561st largest listed company in the world and the 2,536th largest in the USA on this site. In the year to December 2025 it had sales of $85 M and a net profit of $3 M, about 3 cents of profit for every dollar of sales. It employs about 156 people and Gerard J. Michel is its chief executive. Its largest product and service lines by sales in 2025 were HEPZATO KIT (92%) and CHEMOSAT (8%). By market, the largest shares of its 2025 sales came from USA (92%). Its shares trade under the symbol DCTH (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Delcath Systems, Inc.
We are an interventional oncology company focused on the treatment of cancers primary or metastatic to the liver. Our lead product, the HEPZATOTM KIT (melphalan for Injection/Hepatic Delivery System), a drug/device combination product, was approved by the US Food and Drug Administration on August 14, 2023, indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection, or radiation. The first commercial use of the HEPZATO for the treatment of metastatic hepatic dominant uveal melanoma took place in January 2024.
From the company's annual report filed with the US SEC: read the report
Delcath Systems, Inc. timeline
- 2000
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2025
- 💰Record revenue of $85 millionFY2025, the highest of the 5 years on record.
Events of Delcath Systems, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,863 (Jan 2022) · #4,992 (Dec 2022) · #4,796 (Jul 2023) · #3,760 (Jan 2024) · #1,500 (Mar 2026) · #2,440 (Aug 2026) · #2,485 (Oct 2026) · #2,539 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 75.2×
- Price / sales (TTM)
- 4.5×
- Price / book
- 4.5×
- Free cash flow yield
- 4.2%
- Net margin (TTM)
- 6.0%
- Operating margin
- 0.8%
- Return on equity
- 6.0%
- Liabilities / assets
- 10.0%
- Net debt
- $-32M
- Revenue growth
- +129.1%
- R&D / revenue
- 34.3%
- Revenue per employee
- $546 K
- Profit per employee
- $17 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $85M | +129.1% | $1M | $3M | 3.2% |
| Dec 2024 | $37M | +1705.8% | $-12M | $-26M | -70.9% |
| Dec 2023 | $2M | -24.3% | $-38M | $-48M | -2314.6% |
| Dec 2022 | $3M | -23.6% | $-34M | $-37M | -1342.3% |
| Dec 2021 | $4M | — | $-25M | $-26M | -720.5% |
| Dec 2020 | — | — | $-21M | $-24M | — |
| Dec 2019 | — | — | $-20M | $-9M | — |
| Dec 2018 | — | — | $-27M | $-19M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $23M | $2M | $21M | $0.07 | — |
| Dec 2024 | $-19M | $1M | $-19M | $-0.93 | — |
| Dec 2023 | $-31M | $0M | $-31M | $-2.94 | — |
| Dec 2022 | $-25M | $0M | $-25M | $-4.12 | — |
| Dec 2021 | $-23M | $0M | $-23M | $-3.59 | — |
| Dec 2020 | $-23M | $1M | $-24M | $-8.35 | — |
| Dec 2019 | $-24M | $0M | $-24M | $-342.83 | — |
| Dec 2018 | $-15M | $0M | $-15M | $-0.72 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $35M (+70.7% on a year earlier), net income $7M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 9, 202610-QQuarterly report · period to Sep 2026
- Nov 9, 20268-KCurrent reportResults of operations
- Aug 14, 20268-KCurrent reportBylaws amended
- Aug 6, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportResults of operations
- May 14, 20268-KCurrent reportDirectors or officers changed · Shareholder vote
- May 7, 202610-QQuarterly report · period to Mar 2026
- May 7, 20268-KCurrent reportResults of operations
- Apr 2, 2026DEF 14AProxy statement
- Mar 3, 20268-KCurrent reportOther events
- Feb 26, 202610-KAnnual report · period to Dec 2025
- Feb 26, 20268-KCurrent reportResults of operations
Official filings of Delcath Systems, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $85 M
- Operating income
- $1 M
- Net income
- $3 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $124 M
- Total liabilities
- $12 M
- Total equity
- $111 M
As of December-2025
Top 100 institutional investors in Delcath Systems, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3,996,569 | +1,289,767 (+47.65%) | 11.49% | $64 M | Nov 13, 2026 |
| 2 | Rosalind Advisors, Inc. | 3,300,389 | 0 (0.00%) | 9.49% | $53 M | Nov 16, 2026 |
| 3 | Vanguard Capital Management LLC | 1,229,641 | +8,394 (+0.69%) | 3.53% | $20 M | Nov 13, 2026 |
| 4 | ExodusPoint Capital Management, LP | 862,710 | +502,826 (+139.72%) | 2.48% | $14 M | Nov 16, 2026 |
| 5 | Geode Capital Management, LLC | 822,901 | +89,786 (+12.25%) | 2.37% | $13 M | Nov 6, 2026 |
| 6 | Algert Global LLC | 773,999 | +193,291 (+33.29%) | 2.22% | $12 M | Nov 17, 2026 |
| 7 | State Street Corp | 759,942 | +80,662 (+11.87%) | 2.18% | $12 M | Nov 12, 2026 |
| 8 | Millennium Management LLC | 608,023 | +41,652 (+7.35%) | 1.75% | $10 M | Nov 16, 2026 |
| 9 | Propel Bio Management, LLC | 604,664 | -266,796 (-30.61%) | 1.74% | $10 M | Nov 13, 2026 |
| 10 | Morgan Stanley | 550,557 | +142,574 (+34.95%) | 1.58% | $9 M | Nov 13, 2026 |
| 11 | Marshall Wace, LLP | 371,893 | +152,930 (+69.84%) | 1.07% | $6 M | Nov 13, 2026 |
| 12 | Goldman Sachs Group Inc | 368,763 | +118,451 (+47.32%) | 1.06% | $6 M | Nov 16, 2026 |
| 13 | Arrowstreet Capital, Limited Partnership | 356,926 | New | 1.03% | $6 M | Nov 13, 2026 |
| 14 | Vanguard Portfolio Management LLC | 335,171 | +141,723 (+73.26%) | 0.96% | $5 M | Nov 13, 2026 |
| 15 | Dimensional Fund Advisors LP | 314,903 | +104,605 (+49.74%) | 0.91% | $5 M | Nov 4, 2026 |
| 16 | Private Wealth Advisors, LLC | 289,028 | -21,835 (-7.02%) | 0.83% | $5 M | Nov 16, 2026 |
| 17 | Northern Trust Corp | 248,821 | -3,287 (-1.30%) | 0.72% | $4 M | Nov 16, 2026 |
| 18 | Simplify Asset Management Inc. | 227,679 | -37,091 (-14.01%) | 0.65% | $4 M | Oct 27, 2026 |
| 19 | ADAR1 Capital Management, LLC | 224,385 | 0 (0.00%) | 0.65% | $4 M | Nov 16, 2026 |
| 20 | Kennedy Capital Management LLC | 197,978 | -6,165 (-3.02%) | 0.57% | $3 M | Nov 13, 2026 |
| 21 | Vanguard Fiduciary Trust Co | 192,857 | +10,954 (+6.02%) | 0.55% | $3 M | Nov 13, 2026 |
| 22 | AQR Capital Management LLC | 190,051 | +17,058 (+9.86%) | 0.55% | $3 M | Nov 16, 2026 |
| 23 | Nuveen, LLC | 170,335 | -11,260 (-6.20%) | 0.49% | $3 M | Nov 10, 2026 |
| 24 | Tudor Investment Corp Et Al | 168,318 | +156,276 (+1297.76%) | 0.48% | $3 M | Nov 16, 2026 |
| 25 | Jpmorgan Chase & Co | 150,424 | +137,486 (+1062.65%) | 0.43% | $2 M | Nov 12, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Barclays PLC | 147,166 | +39,216 (+36.33%) | 0.42% | $2 M | Nov 6, 2026 |
| 27 | Lane Generational LLC | 143,971 | -5,692 (-3.80%) | 0.41% | $2 M | Nov 9, 2026 |
| 28 | HSBC Holdings PLC | 143,474 | +7,874 (+5.81%) | 0.41% | $2 M | Nov 16, 2026 |
| 29 | Ikarian Capital, LLC | 135,667 | -50,000 (-26.93%) | 0.39% | $2 M | Nov 16, 2026 |
| 30 | Gsa Capital Partners LLP | 128,151 | +42,201 (+49.10%) | 0.37% | $2 M | Nov 16, 2026 |
| 31 | Man Group plc | 120,622 | -7,873 (-6.13%) | 0.35% | $2 M | Nov 16, 2026 |
| 32 | Acadian Asset Management LLC | 114,009 | New | 0.33% | $2 M | Nov 9, 2026 |
| 33 | Bank of New York Mellon Corp | 112,013 | +3,854 (+3.56%) | 0.32% | $2 M | Nov 5, 2026 |
| 34 | CIBC World Market Inc. | 111,982 | -51,226 (-31.39%) | 0.32% | $2 M | Nov 10, 2026 |
| 35 | Ameriprise Financial Inc | 95,094 | New | 0.27% | $2 M | Nov 16, 2026 |
| 36 | Jump Financial, LLC | 93,589 | +5,554 (+6.31%) | 0.27% | $1 M | Nov 13, 2026 |
| 37 | Russell Investments Group, Ltd. | 88,727 | +21,069 (+31.14%) | 0.26% | $1 M | Nov 6, 2026 |
| 38 | Jefferies Financial Group Inc. | 83,980 | 0 (0.00%) | 0.24% | $1 M | Nov 5, 2026 |
| 39 | Charles Schwab Investment Management Inc | 83,519 | +54 (+0.06%) | 0.24% | $1 M | Nov 16, 2026 |
| 40 | Capital Advisors Wealth Management, LLC | 83,500 | -9,500 (-10.22%) | 0.24% | $1 M | Oct 9, 2026 |
| 41 | Bank Of America Corp /de/ | 79,621 | +18,097 (+29.41%) | 0.23% | $1 M | Nov 16, 2026 |
| 42 | Citadel Advisors LLC | 69,178 | +54,135 (+359.87%) | 0.20% | $1 M | Nov 16, 2026 |
| 43 | Franklin Templeton Inc | 64,906 | New | 0.19% | $1 M | Nov 12, 2026 |
| 44 | SEI Investments Co | 63,378 | +32,009 (+102.04%) | 0.18% | $1 M | Nov 10, 2026 |
| 45 | Point72 Asset Management, L.P. | 61,977 | New | 0.18% | $1 M | Nov 16, 2026 |
| 46 | BNP Paribas Financial Markets | 61,271 | +3,617 (+6.27%) | 0.18% | $1 M | Nov 12, 2026 |
| 47 | Strs Ohio | 59,000 | New | 0.17% | $1 M | Oct 30, 2026 |
| 48 | UBS Group AG | 54,479 | +12,765 (+30.60%) | 0.16% | $1 M | Nov 10, 2026 |
| 49 | Boothbay Fund Management, LLC | 52,885 | +27,509 (+108.41%) | 0.15% | $1 M | Nov 16, 2026 |
| 50 | Informed Momentum Co LLC | 52,359 | New | 0.15% | $1 M | Nov 16, 2026 |
| 51 | Creative Planning | 52,208 | +3,774 (+7.79%) | 0.15% | $1 M | Nov 2, 2026 |
| 52 | Aquatic Capital Management LLC | 49,745 | New | 0.14% | $1 M | Nov 16, 2026 |
| 53 | Alps Advisors Inc | 45,640 | +10,600 (+30.25%) | 0.13% | $1 M | Nov 3, 2026 |
| 54 | D. E. Shaw & Co., Inc. | 45,023 | -12,871 (-22.23%) | 0.13% | $1 M | Nov 16, 2026 |
| 55 | Rhumbline Advisers | 44,800 | +8,356 (+22.93%) | 0.13% | $1 M | Nov 10, 2026 |
| 56 | American Century Companies Inc | 44,521 | +14,467 (+48.14%) | 0.13% | $1 M | Nov 12, 2026 |
| 57 | Quantbot Technologies LP | 40,420 | -19,140 (-32.14%) | 0.12% | $1 M | Nov 12, 2026 |
| 58 | Occudo Quantitative Strategies LP | 39,067 | New | 0.11% | $1 M | Nov 16, 2026 |
| 59 | Palisades Investment Partners, LLC | 37,818 | +14,545 (+62.50%) | 0.11% | $1 M | Nov 3, 2026 |
| 60 | Citigroup Inc | 35,088 | +21,793 (+163.92%) | 0.10% | $1 M | Nov 4, 2026 |
| 61 | Quadrature Capital Ltd | 34,994 | New | 0.10% | $1 M | Nov 13, 2026 |
| 62 | XTX Topco Ltd | 29,969 | New | 0.09% | $0 M | Nov 16, 2026 |
| 63 | Kopp Family Office, LLC | 28,189 | New | 0.08% | $0 M | Oct 21, 2026 |
| 64 | Alliancebernstein L.P. | 25,800 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 65 | State of Alaska, Department of Revenue | 25,669 | -364 (-1.40%) | 0.07% | $0 M | Oct 15, 2026 |
| 66 | Campbell & CO Investment Adviser LLC | 25,666 | New | 0.07% | $0 M | Nov 13, 2026 |
| 67 | Deutsche Bank AG\ | 25,532 | -3,704 (-12.67%) | 0.07% | $0 M | Nov 6, 2026 |
| 68 | Xcelsior Advisor Partners LLC | 25,300 | 0 (0.00%) | 0.07% | $0 M | Nov 13, 2026 |
| 69 | Price T Rowe Associates Inc /MD/ | 23,796 | +2,317 (+10.79%) | 0.07% | $0 M | Nov 16, 2026 |
| 70 | Los Angeles Capital Management LLC | 22,395 | New | 0.06% | $0 M | Nov 12, 2026 |
| 71 | Susquehanna International Group, LLP | 21,426 | New | 0.06% | $0 M | Nov 16, 2026 |
| 72 | Trexquant Investment LP | 21,109 | New | 0.06% | $0 M | Nov 16, 2026 |
| 73 | Entropy Technologies, LP | 20,553 | New | 0.06% | $0 M | Nov 13, 2026 |
| 74 | Bailard, Inc. | 20,006 | New | 0.06% | $0 M | Oct 13, 2026 |
| 75 | WINTON GROUP Ltd | 18,900 | New | 0.05% | $0 M | Nov 12, 2026 |
| 76 | MetLife Investment Management, LLC | 18,669 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 77 | Engineers Gate Manager LP | 17,550 | New | 0.05% | $0 M | Nov 16, 2026 |
| 78 | WealthPlan Investment Management, LLC | 17,443 | 0 (0.00%) | 0.05% | $0 M | Oct 15, 2026 |
| 79 | Cornerstone Investment Partners, LLC | 17,170 | New | 0.05% | $0 M | Nov 16, 2026 |
| 80 | Invesco Ltd. | 16,910 | -877 (-4.93%) | 0.05% | $0 M | Nov 12, 2026 |
| 81 | Employees Retirement System of Texas | 16,489 | New | 0.05% | $0 M | Nov 10, 2026 |
| 82 | Royal Bank Of Canada | 15,881 | +1,602 (+11.22%) | 0.05% | $0 M | Nov 16, 2026 |
| 83 | Public Employees Retirement System Of Ohio | 14,165 | New | 0.04% | $0 M | Nov 16, 2026 |
| 84 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 13,956 | +713 (+5.38%) | 0.04% | $0 M | Nov 16, 2026 |
| 85 | LPL Financial LLC | 12,072 | +1,837 (+17.95%) | 0.03% | $0 M | Nov 6, 2026 |
| 86 | Mercer Global Advisors Inc /adv | 11,591 | +412 (+3.69%) | 0.03% | $0 M | Nov 16, 2026 |
| 87 | Mariner, LLC | 11,244 | New | 0.03% | $0 M | Nov 12, 2026 |
| 88 | Lanark Financial, Inc. | 11,000 | -954 (-7.98%) | 0.03% | $0 M | Oct 26, 2026 |
| 89 | New York State Common Retirement Fund | 10,900 | +6,100 (+127.08%) | 0.03% | $0 M | Nov 17, 2026 |
| 90 | Vanguard Global Advisers, LLC | 10,775 | +142 (+1.34%) | 0.03% | $0 M | Nov 13, 2026 |
| 91 | Two Sigma Investments, LP | 10,700 | +646 (+6.43%) | 0.03% | $0 M | Nov 16, 2026 |
| 92 | EntryPoint Capital, LLC | 10,662 | -24,099 (-69.33%) | 0.03% | $0 M | Nov 13, 2026 |
| 93 | Nomura Holdings Inc | 10,093 | -6,629 (-39.64%) | 0.03% | $0 M | Nov 16, 2026 |
| 94 | Leonteq Securities AG | 10,000 | -17,699 (-63.90%) | 0.03% | $0 M | Oct 29, 2026 |
| 95 | Wells Fargo & Company/mn | 9,305 | -19,047 (-67.18%) | 0.03% | $0 M | Nov 16, 2026 |
| 96 | Police & Firemen's Retirement System of New Jersey | 8,795 | 0 (0.00%) | 0.03% | $0 M | Nov 9, 2026 |
| 97 | Osaic Holdings, Inc. | 5,829 | +1,043 (+21.79%) | 0.02% | $0 M | Nov 12, 2026 |
| 98 | FMR LLC | 5,568 | +71 (+1.29%) | 0.02% | $0 M | Nov 10, 2026 |
| 99 | Arax Advisory Partners | 3,581 | -540 (-13.10%) | 0.01% | $0 M | Nov 12, 2026 |
| 100 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,170 | +2,816 (+795.48%) | 0.01% | $0 M | Nov 16, 2026 |
Mutual funds holding Delcath Systems, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 889,410 | $11 M | 1.9% | <0.01% | −9.5% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 757,196 | $10 M | 1.6% | 0.01% | +3.3% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 314,275 | $4 M | 0.66% | 0.01% | +5.5% | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 304,809 | $4 M | 0.64% | <0.01% | −2.6% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 229,809 | $3 M | 0.48% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 North Square Dynamic Small Cap FundNorth Square Investments, LLC | 192,363 | $2 M | 0.40% | 0.26% | +184% | May 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 141,229 | $2 M | 0.30% | <0.01% | +282% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 154,942 | $2 M | 0.33% | <0.01% | +5.4% | May 31, 2026 |
| 🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC | 122,700 | $2 M | 0.26% | 0.15% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 140,170 | $2 M | 0.29% | <0.01% | −1.2% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 96,698 | $1 M | 0.20% | 0.08% | +27% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 100,899 | $1 M | 0.21% | 0.02% | new | May 29, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds | 73,405 | $1 M | 0.15% | 0.11% | new | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 70,457 | $1 M | 0.15% | 0.01% | +7.3% | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 70,373 | $1 M | 0.15% | <0.01% | +266% | Jul 31, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 69,314 | $1 M | 0.15% | 0.01% | +605% | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 52,189 | $1 M | 0.11% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 51,878 | $1 M | 0.11% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 43,402 | $1 M | 0.09% | <0.01% | +2.6% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 39,522 | $0 M | 0.08% | <0.01% | −84% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 39,123 | $0 M | 0.08% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 41,083 | $0 M | 0.09% | <0.01% | +1.9% | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 34,175 | $0 M | 0.07% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 34,591 | $0 M | 0.07% | <0.01% | +385% | Jul 31, 2026 |
| 🇺🇸 ALPS Medical Breakthroughs ETFALPS Advisors, Inc. | 35,814 | $0 M | 0.08% | 0.24% | +14% | May 31, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 35,321 | $0 M | 0.07% | 0.04% | −17% | May 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 28,655 | $0 M | 0.06% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 27,330 | $0 M | 0.06% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 28,071 | $0 M | 0.06% | 0.02% | +3.1% | May 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 20,600 | $0 M | 0.04% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 22,609 | $0 M | 0.05% | <0.01% | +250% | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 20,799 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 17,467 | $0 M | 0.04% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 15,583 | $0 M | 0.03% | <0.01% | −12% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 14,954 | $0 M | 0.03% | 0.01% | −2.2% | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 14,284 | $0 M | 0.03% | <0.01% | +8.3% | Jul 31, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 13,736 | $0 M | 0.03% | 0.01% | +5.0% | Jul 31, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 12,977 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 12,489 | $0 M | 0.03% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 11,445 | $0 M | 0.02% | <0.01% | −27% | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 11,270 | $0 M | 0.02% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 11,200 | $0 M | 0.02% | <0.01% | +111% | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 11,200 | $0 M | 0.02% | <0.01% | +111% | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 11,100 | $0 M | 0.02% | <0.01% | +16% | Jun 30, 2026 |
| 🇺🇸 WisdomTree U.S. SmallCap FundWisdomTree Asset Management, Inc. | 10,622 | $0 M | 0.02% | 0.02% | −2.3% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 9,780 | $0 M | 0.02% | <0.01% | +54% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 11,215 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 9,593 | $0 M | 0.02% | <0.01% | −1.6% | Jul 31, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 9,118 | $0 M | 0.02% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 8,023 | $0 M | 0.02% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 6,454 | $0 M | 0.01% | 0.04% | +17% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 6,127 | $0 M | 0.01% | 0.01% | +8.6% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 5,880 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 5,681 | $0 M | 0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC | 5,277 | $0 M | 0.01% | 0.05% | new | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 4,778 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 4,273 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 4,237 | $0 M | <0.01% | 0.01% | +21% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 4,182 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 3,993 | $0 M | <0.01% | <0.01% | −83% | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 4,500 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 3,959 | $0 M | <0.01% | 0.01% | −2.6% | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 3,808 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 3,721 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 3,689 | $0 M | <0.01% | <0.01% | −4.5% | Jul 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 3,440 | $0 M | <0.01% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 3,297 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 3,075 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 2,866 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 2,627 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 2,652 | $0 M | <0.01% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP | 2,307 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 2,231 | $0 M | <0.01% | 0.01% | −11% | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,147 | $0 M | <0.01% | 0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 2,475 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC | 2,023 | $0 M | <0.01% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 1,956 | $0 M | <0.01% | <0.01% | +16% | Jun 30, 2026 |
| 🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC | 1,718 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 1,638 | $0 M | <0.01% | <0.01% | −4.9% | May 31, 2026 |
| 🇺🇸 SA U.S. Small Company FundFocus Advisor Solutions, LLC | 1,306 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 1,288 | $0 M | <0.01% | <0.01% | −35% | Jun 30, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 1,420 | $0 M | <0.01% | <0.01% | +10% | May 31, 2026 |
| 🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS | 1,179 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC | 1,132 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 1,302 | $0 M | <0.01% | <0.01% | new | May 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 1,073 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 1,122 | $0 M | <0.01% | <0.01% | −39% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 1,111 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 909 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 756 | $0 M | <0.01% | <0.01% | −82% | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 741 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC | 693 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC | 575 | $0 M | <0.01% | <0.01% | −6.2% | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 428 | $0 M | <0.01% | <0.01% | −81% | Jun 30, 2026 |
| 🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC | 367 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 324 | $0 M | <0.01% | <0.01% | −84% | Jul 31, 2026 |
| 🇺🇸 Vanguard Growth And Income FundWellington Management Company LLP | 300 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 161 | $0 M | <0.01% | <0.01% | −4.2% | Jul 31, 2026 |
| 🇺🇸 State Street Balanced Index FundSSGA Funds Management, Inc. | 136 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 99 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Delcath Systems, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Bridget A. MartellDirector | Option exercise | +22,500 | $7.850 | $177 K | 22,500 | Form 4 |
| filed | Bridget A. MartellDirector | Sell | -20,570 | $21.66 | $446 K | 1,930 | Form 4 |
| filed | Bridget A. MartellDirector | Sell | -1,930 | $22.26 | $43 K | 0 | Form 4 |
| filed | Rosalind Advisors, Inc.Director | Conversionindirect | +3,627 | — | — | 3.42 M | Form 4 |
| filed | Rosalind Advisors, Inc.Director | Otherindirect | -27,502 | — | — | 3.39 M | Form 4 |
| filed | Sandra PennellChief Financial Officer | Buy | +5,533 | $9.040 | $50 K | 77,018 | Form 4 |
| filed | Gerard J. MichelCHIEF EXECUTIVE OFFICER, Director | Buy | +11,200 | $8.960 | $100 K | 342,034 | Form 4 |
| filed | John Richard SylvesterDirector | Buy | +4,386 | $8.890 | $39 K | 14,936 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Delcath Systems, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-704.23 reverse split ; 1-for-500 reverse split ; 1-for-344.83 reverse split ; 1-for-16 reverse split ; 1-for-16 reverse split in the period to
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q3 2026 | $0M |
| Q2 2026 | Q2 2026 | $0M |
| Q1 2026 | Q1 2026 | $3M |
| Q4 2025 | Q4 2025 | $6M |
| Q3 2025 | Q3 2026 | $0M |
| Q2 2025 | Q2 2026 | $0M |
| Q1 2025 | Q1 2026 | $0M |
| Q1 2012 | Q1 2012 | $0M |
| Q4 2011 | Q4 2011 | $0M |
| Q3 2011 | Q3 2011 | $0M |
| Q2 2011 | Q2 2011 | $0M |
| Q1 2011 | Q1 2012 | $0M |
| Q4 2010 | Q4 2011 | $0M |
| Q3 2010 | Q3 2011 | $0M |
Fails to deliver
- : 232 shares at $14.37
- : 197 shares at $15.32
- : 650 shares at $16.40
- : 2,350 shares at $16.11
- : 696 shares at $15.80
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Delcath Systems, Inc. scorecard#
Passes 11 of the 21 checks that could be worked out: strongest in growth (5 of 5), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 20, 2026.
Valuation0 of 5
- ✗P/E below its peers' median75.2×P/E 75.2× against Medical Devices's median of 24.1×.
- ✗Price to book below its peers' median4.5×Price to book 4.5× against Medical Devices's median of 2.5×.
- ✗Price to sales below its peers' median4.5×Price to sales 4.5× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%4.2%Free cash flow is 4.2% of the market value.
- ✗Earnings yield above the 10-year Treasury yield1.3%Earnings yield 1.3% against the 10-year Treasury's 5.15% on 2026-11-13.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth5 of 5
- ✓Revenue grew in the newest year129.1%Revenue up 129.1% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years215.3%215.3% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median215.3%215.3% a year against Medical Devices's median of 10.8% (73 companies).
- ✓Earnings per share grew in the newest year0.07 vs -0.93Diluted EPS 0.07 in fiscal 2025 against -0.93 the year before (report's currency).
- ✓Net income higher than five years earlier$3 M$3 M in fiscal 2025 against -$24 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability3 of 5
- ✓Profitable in the newest year$3 MNet income $3 M in fiscal 2025.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median0.8%0.8% against Medical Devices's median of -8.2% (86 companies).
- ✗Return on equity above 15%3.0%3.0% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier0.8%0.8% in fiscal 2025 against -1244.5% in 2022.
Financial health2 of 3
- ✓Short-term assets cover short-term liabilities10.9×Current ratio 10.92 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone19.94Z-score 19.94 (safe zone) for fiscal 2025.
Shareholder returns1 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year40.0%Diluted shares up 40.0% in fiscal 2025.
- ✗Dividends and buybacks above 3% of the market value1.2%Dividends and buybacks were 1.2% of the market value.
- ✓Free cash flow covers dividends and buybacks$21 MFree cash flow $21 M against $6 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Delcath Systems, Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 0.8% | -8.2% | |
| Net margin | 3.2% | -10.4% | |
| Return on equity | 3.0% | -16.8% | |
| Revenue growth, 3 years a year | 215.3% | 10.8% | |
| Revenue growth | 129.1% | 10.4% | |
| Free cash flow margin | 24.6% | -1.9% |
6of 8on the Piotroski tests of financial strength
- The share count rose 40.0% in the year.
Delcath Systems, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 85+129%100% | 37+1702%100% | 2.1−24.1%100% | 2.7−23.5%100% | 3.6—100% | — | — | — | 2.7+36.3%100% | 2.0—100% | |
| Cost of revenue | 12+90.6%13.8% | 6.2+874%16.6% | 0.6−7.4%30.8% | 0.7+2.2%25.2% | 0.7+4.8%18.9% | 0.6−11.0%— | 0.7−28.7%— | 1.0+43.9%— | 0.7+27.5%25.8% | 0.6—27.6% | |
| Gross profit | 73+137%86.2% | 31+2069%83.4% | 1.4−29.7%69.2% | 2.0−29.5%74.8% | 2.9+187%81.1% | 1.0+16.8%— | 0.9−64.1%— | 2.4+19.1%— | 2.0+39.7%74.2% | 1.4—72.4% | |
| Research and development | 29+111%34.3% | 14−20.7%37.3% | 18−5.8%848% | 19+34.9%683% | 14+23.0%388% | 11+18.0%— | 9.5−51.7%— | 20+87.2%— | 10+24.2%387% | 8.4—424% | |
| Selling, general and administrative | 44+47.3%51.1% | 30+33.7%79.4% | 22+27.8%1071% | 17+26.9%636% | 14+22.8%384% | 11−1.5%— | 11+14.9%— | 9.8+1.4%— | 9.7+2.6%357% | 9.4—474% | |
| Operating expenses | 73+67.6%85.4% | 43+9.6%117% | 40+10.4%1918% | 36+30.9%1320% | 27+22.9%771% | 22+7.4%— | 21−29.5%— | 29+46.0%— | 20+12.8%743% | 18—898% | |
| Operating income | 0.7—0.8% | −12—−33.4% | −38—−1849% | −34—−1245% | −25—−690% | −21—— | −20—— | −27—— | −18—−669% | −16—−825% | |
| Interest and finance income | — | — | — | — | — | — | — | — | — | 0.0—0.9% | |
| Interest expense and finance costs | — | — | — | — | — | — | — | — | 22+51.5%799% | 14—719% | |
| Other non-operating income (expense) | −0.1—−0.1% | −0.0—−0.1% | −0.1−297%−2.9% | 0.0−55.9%1.1% | 0.1−55.8%1.9% | 0.2+7600%— | 0.0−96.1%— | 0.1—— | −0.0−341%−1.5% | 0.0r−14—0.9% | |
| Income before tax | 3.5—4.1% | −26—−70.9% | −48—−2309% | −37—−1343% | −26—−721% | −24—— | −8.9—— | −19—— | −45—−1662% | −18—−902% | |
| Income tax | 0.8—1.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—— | 0—— | 0—— | 0—0.0% | 0—0.0% | |
| Net income including minority interests | — | — | — | — | −26—−721% | −24—— | — | −19—— | −45—−1662% | — | |
| Minority interests' share of net income | — | — | — | — | — | 24+173%— | 8.9—— | — | — | — | |
| Net income attributable to shareholders | 2.7—3.2% | −26—−70.9% | −48—−2309% | −37—−1343% | −26—−721% | −24—— | −8.9—— | −19—— | −45—−1662% | −18—−902% | |
| Earnings per share, basic | 0.08—— | -0.93—— | -2.94—— | -4.12—— | -3.59—— | -8.35—— | -342.83r-1,047.00—— | -0.72—— | -3,250.00r-6.50—— | -3,707.00r-10.59—— | |
| Earnings per share, diluted | 0.07—— | -0.93—— | -2.94—— | -4.12—— | -3.59—— | -8.35—— | -342.83r-1,047.00—— | -0.72—— | -3,250.00r-6.50—— | -3,707.00r-10.59—— | |
| Shares, weighted average (basic) | 36+25.6%— | 29+75.7%— | 16+83.1%— | 8.9+24.1%— | 7.1+147%— | 2.9+11089%— | 0.0−99.9%— | 27+190123%— | 0.0—— | — | |
| Shares, weighted average (diluted) | 40+40.0%— | 29+75.7%— | 16+83.1%— | 8.9+24.1%— | 7.1+147%— | 2.9+11089%— | 0.0−99.9%— | 27+190123%— | 0.0r7.0+190%— | 0.0r1.7—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 43+34.1%35.1% | 32+156%42.3% | 13+64.9%32.8% | 7.7−66.4%42.9% | 23−20.2%68.8% | 29+186%82.5% | 10+298%70.4% | 2.5−37.1%36.8% | 4.0−9.3%45.0% | 4.4—12.5% | |
| Short-term investments | 48+129%38.5% | 21+5.1%27.2% | 20—51.3% | 0—0.0% | — | — | — | — | — | — | |
| Receivables | 12+7.8%9.5% | 11+4419%14.2% | 0.2−34.2%0.6% | 0.4+732%2.0% | 0.0−22.8%0.1% | 0.1+171%0.2% | 0.0−96.4%0.1% | 0.6+84.5%8.5% | 0.3−21.3%3.6% | 0.4—1.1% | |
| Inventory | 10+47.9%8.3% | 6.9+109%9.1% | 3.3+66.3%8.6% | 2.0+41.5%11.2% | 1.4+65.1%4.3% | 0.9+30.7%2.5% | 0.7−23.8%4.6% | 0.9−31.3%12.5% | 1.2+89.1%14.0% | 0.7—1.9% | |
| Other current assets | 6.5+140%5.3% | 2.7+148%3.5% | 1.1−44.6%2.8% | 2.0−28.2%11.0% | 2.7+2.7%8.3% | 2.7+51.8%7.7% | 1.8+95.9%12.4% | 0.9+28.3%13.1% | 0.7+0.3%7.9% | 0.7—2.0% | |
| Current assets | 120+62.1%96.7% | 74+98.5%96.3% | 37+130%96.2% | 16−48.1%90.4% | 31−3.7%94.0% | 32+156%93.4% | 13+113%88.8% | 5.9−22.0%86.5% | 7.6−77.8%85.4% | 34—96.9% | |
| Property, plant and equipment | 3.2+76.9%2.6% | 1.8+32.4%2.3% | 1.4−4.9%3.5% | 1.4+5.5%8.0% | 1.3−0.2%4.1% | 1.4+83.8%3.9% | 0.7−20.5%5.2% | 0.9−28.7%13.5% | 1.3+19.9%14.6% | 1.1—3.1% | |
| Right-of-use (leased) assets | 0.9−9.9%0.8% | 1.0+909%1.4% | 0.1−63.9%0.3% | 0.3−54.3%1.6% | 0.6−34.0%1.9% | 0.9+10.0%2.7% | 0.9—6.1% | 0—0.0% | — | — | |
| Total assets | 124+61.4%100% | 77+98.4%100% | 39+116%100% | 18−46.1%100% | 33−4.4%100% | 35+144%100% | 14+108%100% | 6.8−23.0%100% | 8.9−74.8%100% | 35—100% | |
| Accounts payable | 2.7+177%2.1% | 1.0−5.0%1.3% | 1.0−49.9%2.6% | 2.0+216%11.3% | 0.6−64.0%1.9% | 1.8−60.9%5.1% | 4.5−41.2%31.9% | 7.7+101%113% | 3.8+547%43.3% | 0.6—1.7% | |
| Current liabilities | 11+78.2%8.9% | 6.1−62.6%8.0% | 16+11.6%42.6% | 15+147%82.5% | 6.0−40.7%18.0% | 10−37.3%29.0% | 16r16−9.9%113% | 18+127%259% | 7.8−78.4%87.9% | 36—102% | |
| Lease liabilities (non-current) | 0.8−10.5%0.7% | 0.9—1.2% | 0—0.0% | — | 0.2−54.0%0.6% | 0.5+128%1.3% | 0.2—1.4% | 0—0.0% | — | — | |
| Total liabilities | 12+58.3%10.0% | 7.8−65.7%10.2% | 23−3.7%59.1% | 24+12.0%133% | 21+68.6%63.9% | 13−39.0%36.3% | 21−5.6%145% | 22+165%318% | 8.2−77.6%92.4% | 37—104% | |
| Retained earnings | −529—−428% | −532—−694% | −505—−1308% | −457—−2561% | −421—−1271% | −395—−1141% | −371—−2612% | −344—−5027% | −325—−3655% | −279—−792% | |
| Shareholders' equity | 111+61.8%90.0% | 69+336%89.8% | 16—40.9% | −5.9−149%−32.8% | 12−45.9%36.1% | 22—63.7% | −6.4—−44.7% | −15−2303%−218% | 0.7—7.6% | −1.5—−4.2% | |
| Total liabilities and equity | 124+61.4%100% | 77+98.4%100% | 39+116%100% | 18−46.1%100% | 33−4.4%100% | 35+144%100% | 14+108%100% | 6.8−23.0%100% | 8.9−74.8%100% | 35—100% | |
| Shares outstanding | 35+4.9%— | 33+45.2%— | 23+127%— | 10r7.9+27.1%— | 7.9+31.9%— | 6.0+8837%— | 0.1+356%— | 0.0r10−93.5%— | 0.2r114+1842%— | 0.0r4.1—— | |
| Cash-flow statement | |||||||||||
| Share-based compensation | 24+148%28.4% | 9.8+19.8%26.3% | 8.2+2.6%395% | 7.9—292% | — | — | — | — | — | — | |
| Cash from operating activities | 23—26.4% | −19—−50.2% | −31—−1513% | −25—−918% | −23—−636% | −23—— | −24r−24—— | −15—— | −15—−567% | −14—−714% | |
| Capital expenditure | −1.5—−1.8% | −0.6—−1.5% | −0.1—−2.8% | −0.2—−7.7% | −0.1—−4.0% | −0.8—— | −0.0—— | −0.1—— | −0.5—−19.3% | −0.3—−13.0% | |
| Cash from investing activities | −27—−31.2% | −1.0—−2.6% | −20—−954% | −0.2—−7.7% | −0.1—−4.0% | −0.8—— | −0.0—— | −0.1—— | −0.5—−19.3% | −1.3—−67.5% | |
| Debt issued | — | — | — | — | 15—422% | 0−100%— | 3.7—— | 0—— | — | — | |
| Debt repaid | 0—0.0% | −11—−28.5% | −6.3—−306% | −0.7—−26.3% | — | — | — | — | — | — | |
| Shares issued | 0.5+92.4%0.6% | 0.3+103%0.7% | 0.1—6.0% | 0−100%0.0% | 2.5r2.5+987%70.3% | 0.2—— | 0−100%— | 11—— | — | — | |
| Shares bought back | −6.0—−7.0% | 0—0.0% | — | — | — | — | — | — | — | — | |
| Cash from financing activities | 15−61.8%17.7% | 39−23.9%106% | 52+410%2507% | 10−51.3%373% | 21−50.8%586% | 42+39.8%— | 30+129%— | 13—— | −11r15−242%−387% | 7.4—372% | |
| Change in cash | 11−44.0%13.0% | 20+2156%53.0% | 0.9—42.3% | −15—−556% | −1.8−110%−50.7% | 19+181%— | 6.6r6.6—— | −1.7—— | −26r−0.4—−971% | −8.2—−412% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 110+38.1%100% | 35+70.7%100% | 29+20.6%100% | 25+26.3%100% | 21*+37.3%100% | 21+83.6%100% | 24+211%100% | 20+530%100% | 15*+2701%100% | 11—100% | 7.8—100% | 3.1—100% | 0.5*—100% | |
| Cost of revenue | 14+25.1%12.4% | 3.9+49.3%11.2% | 3.0−10.0%10.2% | 3.7+31.3%14.9% | 3.0*+41.6%14.5% | 2.6+60.0%12.8% | 3.3+118%13.7% | 2.8+215%14.4% | 2.1*+1143%14.1% | 1.6—14.6% | 1.5—19.6% | 0.9—28.8% | 0.2*—31.7% | |
| Gross profit | 96+40.2%87.6% | 31+73.8%88.8% | 26+25.5%89.8% | 21+25.5%85.1% | 18*+36.6%85.5% | 18+87.6%87.2% | 21+234%86.3% | 17+658%85.6% | 13*+3426%85.9% | 9.6—85.4% | 6.2—80.4% | 2.2—71.2% | 0.4*—68.3% | |
| Research and development | 41+78.1%36.9% | 11+37.9%31.4% | 10+50.8%35.6% | 9.8+96.2%39.3% | 9.4*+222%45.2% | 8.0+107%38.8% | 6.9+103%28.5% | 5.0+35.3%25.3% | 2.9*−38.1%19.3% | 3.9—34.5% | 3.4—43.7% | 3.7—118% | 4.7*—874% | |
| Selling, general and administrative | 50+25.0%45.5% | 13+26.3%37.2% | 13+17.7%45.9% | 13+15.8%52.3% | 11*+50.0%50.8% | 10+48.7%50.3% | 11+68.0%47.1% | 11+28.1%57.1% | 7.0*+0.8%46.5% | 7.0—62.1% | 6.8—87.1% | 8.8—281% | 7.0*—1292% | |
| Operating expenses | 91+44.3%82.4% | 24+31.3%68.6% | 24+30.2%81.5% | 23+40.5%91.6% | 20*+100%96.0% | 18+69.4%89.1% | 18+79.6%75.5% | 16+30.2%82.4% | 9.9*−14.9%65.8% | 11—96.6% | 10—131% | 13—399% | 12*—2165% | |
| Operating income | 5.7−3.3%5.2% | 7.1—20.3% | 2.4−7.5%8.2% | −1.6−355%−6.5% | −2.2*−172%−10.5% | −0.4—−1.9% | 2.6—10.7% | 0.6—3.2% | 3.0*—20.1% | −1.3—−11.2% | −3.9—−50.4% | −10—−327% | −11*—−2097% | |
| Other non-operating income (expense) | −0.1—−0.1% | −0.0—−0.0% | −0.0—−0.1% | −0.1−1550%−0.2% | −0.0*—−0.0% | −0.0−194%−0.2% | −0.0−440%−0.1% | 0.0—0.0% | −0.1*—−0.4% | 0.0—0.3% | 0.0—0.1% | −0.0—−0.7% | −0.1*—−13.5% | |
| Income before tax | 8.9+514%8.1% | 8.0+2025%22.7% | 3.2−1.4%10.8% | −0.9−172%−3.6% | −1.3*—−6.4% | 0.4−79.9%1.8% | 3.2—13.3% | 1.3—6.4% | −3.4*—−22.5% | 1.9—16.6% | −14—−177% | −11—−354% | — | |
| Income tax | 2.2+799%2.0% | 1.0—2.9% | 0.5−3.3%1.7% | 0.2−16.9%0.6% | 0.6*—2.7% | −0.5—−2.2% | 0.5—2.1% | 0.2—1.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | |
| Net income attributable to shareholders | 6.7+455%6.1% | 7.0+738%19.8% | 2.7−1.1%9.2% | −1.1−200%−4.3% | −1.9*—−9.1% | 0.8−55.5%4.0% | 2.7—11.2% | 1.1—5.4% | −3.4*—−22.5% | 1.9—16.6% | −14—−177% | −11—−354% | −11*—−2066% | |
| Earnings per share, basic | — | 0.19+850%— | 0.07−12.5%— | -0.03−200%— | — | 0.02−66.7%— | 0.08—— | 0.03—— | — | 0.06—— | -0.48—— | -0.45—— | — | |
| Earnings per share, diluted | — | 0.17+750%— | 0.070.0%— | -0.03−200%— | — | 0.02−66.7%— | 0.07—— | 0.03—— | — | 0.06—— | -0.48—— | -0.45—— | — | |
| Shares, weighted average (basic) | 36−0.8%— | 36−0.8%— | 36+0.3%— | 36+4.0%— | — | 36+26.6%— | 36+26.2%— | 35+39.2%— | — | 29—— | 28—— | 25—— | — | |
| Shares, weighted average (diluted) | 41+2.4%— | 41+2.4%— | 40−1.2%— | 36−8.8%— | — | 40+23.8%— | 40+41.9%— | 40+58.8%— | — | 32—— | 28—— | 25—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 56—37.3% | 56+32.8%37.3% | 48+38.1%34.7% | 41+223%33.1% | 43+34.1%35.1% | 42+403%33.6% | 34+133%29.5% | 13+8.6%14.6% | 32+156%42.3% | 8.3—26.2% | 15—43.6% | 12—32.6% | 13—32.8% | |
| Short-term investments | 49—32.7% | 49+3.6%32.7% | 48+3.9%35.3% | 48+4.0%38.4% | 48+129%38.5% | 47+730%37.9% | 47+809%39.9% | 46+200%52.8% | 21+5.1%27.2% | 5.7—17.9% | 5.1—15.1% | 15—42.5% | 20—51.3% | |
| Receivables | 20—13.6% | 20+47.0%13.6% | 16+0.7%11.6% | 14+1.6%11.3% | 12+7.8%9.5% | 14+98.3%11.1% | 16+325%13.5% | 14+791%16.0% | 11+4419%14.2% | 6.9—21.9% | 3.7—11.0% | 1.6—4.3% | 0.2—0.6% | |
| Inventory | 11—7.0% | 11−2.3%7.0% | 12+11.3%8.5% | 9.8+37.5%7.9% | 10+47.9%8.3% | 11+61.8%8.6% | 11+66.6%9.0% | 7.1+96.3%8.2% | 6.9+109%9.1% | 6.6—21.0% | 6.3—18.6% | 3.6—10.1% | 3.3—8.6% | |
| Other current assets | 6.5—4.4% | 6.5−9.5%4.4% | 7.0+14.1%5.1% | 7.0+59.9%5.6% | 6.5+140%5.3% | 7.2+449%5.8% | 6.1+322%5.2% | 4.4+243%5.0% | 2.7+148%3.5% | 1.3—4.1% | 1.5—4.3% | 1.3—3.5% | 1.1—2.8% | |
| Current assets | 142—94.9% | 142+17.4%94.9% | 131+15.0%95.3% | 120+42.6%96.3% | 120+62.1%96.7% | 121+318%97.0% | 113+261%97.1% | 84+151%96.6% | 74+98.5%96.3% | 29—91.2% | 31—92.6% | 34—93.2% | 37—96.2% | |
| Property, plant and equipment | 5.1—3.4% | 5.1+88.8%3.4% | 4.0+67.4%2.9% | 3.7+87.4%2.9% | 3.2+76.9%2.6% | 2.7+57.0%2.2% | 2.4+68.8%2.1% | 2.0+46.3%2.2% | 1.8+32.4%2.3% | 1.7—5.5% | 1.4—4.2% | 1.3—3.7% | 1.4—3.5% | |
| Right-of-use (leased) assets | 2.4—1.6% | 2.4+150%1.6% | 2.5+148%1.8% | 0.9−10.7%0.7% | 0.9−9.9%0.8% | 1.0−9.8%0.8% | 1.0−9.1%0.8% | 1.0−9.0%1.2% | 1.0+909%1.4% | 1.1—3.4% | 1.1—3.2% | 1.1—3.1% | 0.1—0.3% | |
| Total assets | 149—100% | 149+19.9%100% | 137+17.2%100% | 125+43.0%100% | 124+61.4%100% | 124+292%100% | 117+245%100% | 87+142%100% | 77+98.4%100% | 32—100% | 34—100% | 36—100% | 39—100% | |
| Accounts payable | 3.5—2.3% | 3.5+62.9%2.3% | 4.0−14.9%2.9% | 3.5+114%2.8% | 2.7+177%2.1% | 2.1+128%1.7% | 4.7+43.8%4.0% | 1.6+8.9%1.9% | 1.0−5.0%1.3% | 0.9—3.0% | 3.3—9.7% | 1.5—4.1% | 1.0—2.6% | |
| Current liabilities | 13—8.7% | 13+62.6%8.7% | 13+27.3%9.7% | 11+102%8.6% | 11+78.2%8.9% | 8.0−62.9%6.4% | 10−15.1%8.9% | 5.3−60.4%6.1% | 6.1−62.6%8.0% | 22—68.1% | 12—36.2% | 13—37.0% | 16—42.6% | |
| Lease liabilities (non-current) | 2.2—1.5% | 2.2+159%1.5% | 2.3+158%1.7% | 0.8−10.0%0.7% | 0.8−10.5%0.7% | 0.9−11.2%0.7% | 0.9−11.3%0.8% | 0.9−10.8%1.0% | 0.9—1.2% | 1.0—3.0% | 1.0—2.9% | 1.0—2.8% | 0—0.0% | |
| Total liabilities | 16—10.4% | 16+64.6%10.4% | 16+33.5%11.6% | 12+71.1%9.7% | 12+58.3%10.0% | 9.4−59.1%7.6% | 12−60.0%10.2% | 7.1−67.0%8.1% | 7.8−65.7%10.2% | 23—72.9% | 30—87.6% | 21—59.5% | 23—59.1% | |
| Retained earnings | −520—−349% | −520—−349% | −527—−385% | −530—−424% | −529—−428% | −527—−424% | −528—−452% | −530—−608% | −532—−694% | −528—−1667% | −530—−1563% | −516—−1430% | −505—−1308% | |
| Shareholders' equity | 134—89.6% | 134+16.3%89.6% | 121+15.4%88.4% | 113+40.5%90.3% | 111+61.8%90.0% | 115+1240%92.4% | 105+2404%89.8% | 80+449%91.9% | 69+336%89.8% | 8.6—27.1% | 4.2—12.4% | 15—40.5% | 16—40.9% | |
| Total liabilities and equity | 149—100% | 149+19.9%100% | 137+17.2%100% | 125+43.0%100% | 124+61.4%100% | 124+292%100% | 117+245%100% | 87+142%100% | 77+98.4%100% | 32—100% | 34—100% | 36—100% | 39—100% | |
| Shares outstanding | 35—— | 35−1.5%— | 35−0.9%— | 34+3.1%— | 35+4.9%— | 35+26.0%— | 35+25.1%— | 33+31.4%— | 33+45.2%— | 28—— | 28—— | 25—— | 23—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 19−11.8%17.1% | 4.2−25.1%12.1% | 5.1−29.0%17.6% | 4.9−27.9%19.8% | 4.5*+180%21.8% | 5.6+164%27.5% | 7.2+135%29.8% | 6.9+133%34.7% | 1.6*−19.4%10.7% | 2.1—19.1% | 3.1—39.5% | 2.9—93.8% | 2.0*—371% | |
| Cash from operating activities | 23+73.4%20.9% | 8.2*+71.3%23.3% | 5.7*−21.7%19.6% | 0.9−61.1%3.4% | 8.2*—39.8% | 4.8*—23.2% | 7.3*—30.2% | 2.2—11.1% | −1.0*—−6.7% | −3.6*—−32.5% | −4.5*—−57.3% | −9.6—−305% | −8.2*—−1517% | |
| Capital expenditure | −2.9—−2.6% | −1.3*—−3.6% | −0.5*—−1.7% | −0.6—−2.3% | −0.6*—−2.7% | −0.5*—−2.2% | −0.4*—−1.6% | −0.1—−0.7% | −0.2*—−1.5% | −0.2*—−1.9% | −0.1*—−1.3% | −0.0—−0.4% | −0.0*—−3.5% | |
| Cash from investing activities | −2.9—−2.6% | −1.3*—−3.6% | −0.5*—−1.7% | −0.6—−2.3% | −0.6*—−2.7% | −0.5*—−2.3% | −0.4*−104%−1.7% | −25−640%−127% | −15*—−101% | −0.7*—−6.2% | 10*—132% | 4.7—148% | −20*—−3649% | |
| Debt repaid | — | — | — | — | 0*—0.0% | 0*—0.0% | 0*—0.0% | 0—0.0% | −2.0*—−13.2% | −2.5*—−22.3% | −3.1*—−39.3% | −3.1—−97.3% | 0*—0.0% | |
| Shares issued | 0.7+44.7%0.6% | 0.3*+26.3%0.9% | 0*—0.0% | 0.4+63.4%1.6% | 0*—0.0% | 0.2*+38.9%1.2% | 0*—0.0% | 0.2+217%1.2% | 0*—0.0% | 0.2*—1.6% | 0*—0.0% | 0.1—2.4% | 0*—0.0% | |
| Shares bought back | −9.0—−8.2% | 0*—0.0% | −0.0*—−0.0% | −3.0—−12.0% | −6.0*—−28.9% | 0*—0.0% | 0*—0.0% | 0—0.0% | — | — | — | — | — | |
| Cash from financing activities | −6.3−110%−5.7% | 1.1*−64.6%3.1% | 1.0*−93.4%3.3% | −2.4−173%−9.5% | −5.9*−115%−28.7% | 3.1*—15.1% | 15*—60.6% | 3.3−19.1%16.4% | 40*+4038400%267% | −2.1*—−19.1% | −2.9*—−36.7% | 4.0—128% | 0.0*—0.2% | |
| Change in cash | 14−59.0%12.5% | 8.0*+8.5%22.8% | 6.2*−71.3%21.3% | −2.1—−8.6% | 1.6*−93.2%7.9% | 7.4*—35.9% | 22*+628%89.6% | −20—−99.3% | 24*—160% | −6.5*—−57.7% | 3.0*—38.3% | −0.9—−28.2% | −28*—−5161% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Delcath Systems, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- HEPZATO KIT$79 M93%+144%
- CHEMOSAT$6 M7.5%+31%
Countries and regions
- 🇺🇸 USA$79 M93%+144%
- Foreign(total)$6 M7.5%+31%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at Delcath Systems, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Gerard Michel | $5.8 M | $3.1 M | $2.0 M | $281 |
| 2024Gerard Michel | $2.2 M | $4.9 M | $1.0 M | $334 |
| 2023Gerard Michel | $2.5 M | $2.2 M | $1.1 M | $116 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Delcath Systems, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 2 · Auditor changed 1 · Directors and officers 4 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 14
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Auditor changed | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Delisting notice | 8-K | |
| Delisting noticeDirectors and officersShareholder vote | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2024 | $7 M | Private placement after listing | $2 to $10 million | 17 | equity, options | SEC |
| Mar 2023 | $25 M | Private placement after listing | $10 to $50 million | 17 | equity, options | SEC |
| Dec 2022 | $4 M | Private placement after listing | $2 to $10 million | 7 | equity, options | SEC |
| Jul 2022 | $5 M | Private placement after listing | $2 to $10 million | 6 | equity, options | SEC |
| Aug 2019 | $10 M | Private placement after listing | $2 to $10 million | 33 | equity, options | SEC |
| Jul 2019 | $20 M | Private placement after listing | $10 to $50 million | 31 | equity, options | SEC |
| Jul 2018 | $2 M | Private placement after listing | Under $2 million | 1 | debt, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Lobbying by Delcath Systems, Inc.#
$140 K spent on lobbying the US Congress and federal agencies in 2026, most often on health issues.
- Health Issues3 reports
Lobbying firms hired in 2026
BGR Government Affairs $140 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $140 K | — | 3 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Delcath Systems, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
H-1B hiring at Delcath Systems, Inc.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $78 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Regulatory Affairs Associate, PublishingRegulatory Affairs Specialists | 1 | $78 K |
Where: Chandler, AZ 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $78 K | 1 |
| FY2025 | 1 | 1 | $83 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Delcath Systems, Inc.
FDA drug approvals: Delcath Systems, Inc.#
1 approved applications held; 1 approvals and 0 new uses in 2023.
| Approved | Drug | Kind |
|---|---|---|
| 2023-08-14 | HepzatoMelphalan Hydrochloride · NDA201848 | New drug (NDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (DELCATH SYSTEMS INC), so they follow acquisitions
Discuss Delcath Systems, Inc.#
2 automatic updates and 0 member comments. Sign in to comment and react.
- Results announced on 9 November 2026automatic update · Nov 9, 2026
Delcath Systems, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $35 million (up 71% from a year earlier) and net income of $7 million (up 737% from a year earlier).
- Mutual funds: 99 funds hold $56 millionautomatic update · Jul 31, 2026
99 mutual funds in 1 country hold shares of Delcath Systems, Inc. worth $56 million, about 9.7% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 44 funds added shares and 29 sold; on balance they bought $7 million. Share splits are not counted as trading.
How Delcath Systems, Inc. compares in Medical Devices
- Market cap$500 M · higher than 50% of 142
- Revenue$85 M · higher than 38% of 155
- Net margin6.0% · higher than 64% of 144
- Revenue growth129.1% · higher than 96% of 104
- P/E ratio75.2× · lower than 11% of 47
- Price / sales4.5× · lower than 33% of 96
- Price / book4.5× · lower than 33% of 99
- FCF yield4.2% · higher than 83% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Delcath Systems, Inc.🇺🇸 | $500 M | 75.2× | 6.0% | +129.1% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- 908 Devices Inc.$503 M
- NeuroPace, Inc.$487 M
- AK Medical Holdings Limited$537 M
- Tactile Systems Technology, Inc.$545 M
- Sight Sciences, Inc.$448 M
- OrthoPediatrics Corp.$573 M
Sources and freshness
- Market cap:
- Oct 20, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of February 13, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, Wikidata, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Delcath Systems, Inc.? Verify and update this profile — free
Show Delcath Systems, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.